Skip to content

Enhancement of PTSD Treatment With Computerized Executive Function Training

Enhancement of PTSD Treatment With Computerized Executive Function Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03260127
Enrollment
82
Registered
2017-08-24
Start date
2018-07-02
Completion date
2022-10-31
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder

Keywords

PTSD, treatment, posttraumatic stress disorder, therapy, cognition, thinking, executive function, computer, training

Brief summary

This study focuses on helping Iraq and Afghanistan Veterans with posttraumatic stress disorder (PTSD) benefit fully from therapy by first enhancing their thinking abilities. PTSD has been associated with thinking problems, including difficulty planning/organizing, thinking flexibly, and inhibiting distracting emotional information. There is some evidence that computerized training programs are helpful for improving thinking. Therefore, this study tests whether computerized cognitive training will in fact improve individuals' thinking abilities and if this will in turn improve PTSD treatment outcomes and lead to more individuals completing treatment and showing greater improvements in emotional symptoms and quality of life than standard therapy (when paired with a word training condition).

Detailed description

PTSD affects approximately 14% of OEF/OIF Veterans and leads to considerable personal and societal costs (e.g., increased morbidity, reduced work productivity, poorer relationships). Although cognitive behavioral therapy (CBT) is one of the most effective treatments for PTSD, a substantial portion (approximately 50%) of individuals drop out prematurely, do not respond to treatment, or relapse. Treatment engagement is worse for OEF/OIF Veterans, who attend fewer sessions and have higher dropout rates than civilians and Veterans from other eras. One likely barrier to treatment engagement and effectiveness is the executive functioning problems present in individuals with PTSD. Executive functions (EFs) are the set of higher-level cognitive skills that organize and integrate lower-level cognitive processes in order to perform complex, goal-directed tasks. PTSD has been associated with EF deficits, including impairments in inhibitory control, working memory, and cognitive flexibly, as well as dysfunction in a network of brain regions that support EFs (e.g., prefrontal cortex \[PFC\], cingulate). EFs are essential for CBT in order to engage the cognitive skills involved in treatment (e.g., self-monitoring, inhibiting distorted thoughts, and flexibly generating/evaluating alternative thoughts). This is particularly true for Cognitive Processing Therapy (CPT), a frontline CBT treatment for PTSD, which involves identifying and challenging maladaptive trauma-related thoughts to alter their impact on emotions and behavior. Thus, EF deficits may lead to reduced CPT engagement and responsivity. In fact, worse EF at baseline has been associated with poorer response to CBT in several disorders (e.g., generalized anxiety disorder, obsessive compulsive disorder, and schizophrenia). Further, a study of brain functioning during an EF task demonstrated that dysfunction in EF-related brain regions including PFC and cingulate cortex at baseline predicted nonresponse to CBT for PTSD. Directly targeting EF prior to CPT via cognitive training would strengthen executive networks and likely boost treatment effectiveness, allowing Veterans to fully engage in and benefit more from components of CPT (e.g., cognitive restructuring). Evidence suggests that computerized cognitive training improves EF and functioning in EF-related brain regions, increases mental health treatment completion rates, and goal of the proposed study is to examine whether administering computerized EF training (CEFT) immediately prior to CPT will improve executive functioning and enhance treatment adherence, completion rates, and psychological and functional outcomes in OEF/OIF Veterans with PTSD. Objective (neuropsychological) and subjective (self- report) measures of EF will be collected to determine if CEFT enhances EF and if this in turn mediates the relationship between treatment condition and PTSD symptom improvement. Functional neuroimaging during EF tasks will also be collected at baseline to determine whether functioning within an EF network predicts treatment response, above and beyond traditional paper-and-pencil measures of EF. Veterans will be randomized to either 12 weeks of CEFT-CPT or a placebo word training condition plus CPT. Assessments will be administered at baseline, immediately after CEFT or word training (prior to CPT), and after CPT completion. The proposed research aims to reduce barriers to treatment engagement and has potential to significantly enhance current treatments for PTSD by combining cognitive and psychotherapeutic approaches. Targeting EF directly and independently represents a logical, innovative, and empirically-informed method for augmenting existing treatments for PTSD in order to optimize outcomes. Findings from the proposed study will not only directly inform clinical practice, but also have the potential to significantly improve the quality of Veterans' lives, reduce societal costs and burden, improve access to care, and reveal ways to better match individuals with treatments they are most likely to benefit from.

Interventions

BEHAVIORALComputerized executive function training plus CPT (CEFT-CPT)

Participants randomized to the CEFT-CPT arm will receive 6 weeks of computerized executive function training and then 6 weeks of standard Cognitive Processing Therapy for PTSD (total of 12 sessions)

BEHAVIORALWord game training plus CPT (WT-CPT)

Participants randomized to the WT-CPT arm will receive 6 weeks of computerized word game training and then 6 weeks of standard Cognitive Processing Therapy for PTSD (total of 12 sessions)

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans enrolled at Veterans Affairs San Diego Healthcare System (VASDHS) * aged 18-55 * current posttraumatic stress disorder (PTSD) diagnosis * endorsement of cognitive complaints * no pending medication changes * English-speaking.

Exclusion criteria

* active substance use disorder in the last month * suicidal intent or attempt within the last month * schizophrenia, psychotic disorder and/or bipolar disorder * dementia * premorbid IQ \< 70 * participation in other concurrent PTSD intervention studies * previous completion of more than 4 Cognitive Processing Therapy (CPT) sessions * history of a documented neurological disorder (e.g., Parkinson's disease, multiple sclerosis, epilepsy) * moderate to severe traumatic brain injury (TBI) (i.e., loss of consciousness greater than 30 minutes or post-traumatic amnesia greater than 24 hours).

Design outcomes

Primary

MeasureTime frameDescription
Go/No-Go Task Performancechange from baseline to completion of computerized cognitive training (6 weeks)Go/No-Go is a task that tests executive functioning, range: -.04 to .02, higher scores mean a worse outcome
Paced Auditory Serial Addition Test (PASAT)change from baseline to completion of computerized cognitive training (6 weeks)Paced Auditory Serial Addition Test (PASAT) is a neuropsychological measure of executive functioning, will be examined separately as well as in a composite with the other neuropsychological measures of executive functioning, range: -22 to 47, higher scores mean a better outcome
Delis Kaplan Executive Function System (D-KEFS)change from baseline to completion of computerized cognitive training (6 weeks)Delis Kaplan Executive Function System (D-KEFS) is a neuropsychological measure of executive functioning, will be examined separately as well as in a composite with the other neuropsychological measures of executive functioning, range: -39 to 27, higher scores mean a worse outcome
Behavior Rating Inventory of Executive Function (BRIEF)change in subjective executive functioning from baseline to completion of computerized cognitive training (6 weeks)Behavior Rating Inventory of Executive Function (BRIEF) is a self-report measure of executive functioning, items are summed to create a total score, range: -32 to 30, higher scores mean a worse outcome
WAIS-IV Digit Span Sequencing Subtestchange from baseline to completion of computerized cognitive training (6 weeks)Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) Digit Span Sequencing subtest is a neuropsychological measure of executive functioning, will be examined separately as well as in a composite with the other neuropsychological measures of executive functioning, range: -3 to 3, higher scores mean a better outcome
N-Back Task Performancechange from baseline to completion of computerized cognitive training (6 weeks)N-Back is a task that tests executive functioning, range: -.25 to .28, higher scores means a better outcome
Wisconsin Card Sorting Test (WCST)change from baseline to completion of computerized cognitive training (6 weeks)Wisconsin Card Sorting Test (WCST) is a neuropsychological measure of executive functioning, will be examined separately as well as in a composite with the other neuropsychological measures of executive functioning, range: -22 to 15, higher scores mean a worse outcome

Secondary

MeasureTime frameDescription
PTSD Checklist for DSM-5 (PCL-5)change in PTSD symptoms from baseline to completion of Cognitive Processing Therapy (12 sessions completed after cognitive training), approximately 12 weeks after baseline assessmentPTSD Checklist for DSM-5 (PCL-5) is a self-report questionnaire that will be administered at 15 time points: at baseline, after completion of cognitive training, at each of the 12 therapy sessions, and after completion of Cognitive Processing Therapy, range: -49 to 28, higher scores mean a worse outcome
World Health Organization Quality of Life - BREFchange in quality of life from baseline to completion of Cognitive Processing Therapy (12 sessions completed after cognitive training), approximately 12 weeks after baseline assessmentWorld Health Organization Quality of Life - BREF (WHOQOL-BREF) is a self-report questionnaire assessing quality of life that will be administered at 3 time points: baseline, after completion of cognitive training, and after completion of Cognitive Processing Therapy. Four subscales are computed (range 4-20): physical health, psychological, social relationships, and environment, range: -2.7 to 6.7, higher scores mean a better outcome
Time (in Minutes) Spent Completing Cognitive Processing Therapy Homeworktime (in minutes) spent completing homework from CPT session 1 to CPT session 12 (across approximately 6 weeks, weeks 7-12 after baseline)At each of the CPT sessions, participants will report how much time they spent completing homework since the previous session
Number of CPT Sessions CompletedCPT sessions completed (out of a possible 12) after completing the cognitive training (across approximately 6 weeks, weeks 7-12 after baseline)Number of CPT sessions completed out of a possible total of 12 sessions
Clinician-Administered PTSD Scale for DSM 5 (CAPS-5)change in PTSD symptoms from baseline to completion of Cognitive Processing Therapy (12 sessions completed after cognitive training), approximately 12 weeks after baseline assessmentClinician-Administered PTSD Scale for DSM 5 (CAPS-5) is a clinical interview assessing PTSD symptoms that will be administered at 3 time points: baseline, after completion of cognitive training, and after completion of Cognitive Processing Therapy, range: -38 to 18, higher scores mean a worse outcome

Countries

United States

Participant flow

Pre-assignment details

All participants who were were enrolled were randomly assigned to groups.

Participants by arm

ArmCount
CEFT-CPT
Computerized executive function training plus Cognitive Processing Therapy for PTSD Computerized executive function training plus CPT (CEFT-CPT): Participants randomized to the CEFT-CPT arm will receive 6 weeks of computerized executive function training and then 6 weeks of standard Cognitive Processing Therapy for PTSD (total of 12 sessions)
42
WT-CPT
Word game training plus Cognitive Processing Therapy for PTSD Word game training plus CPT (WT-CPT): Participants randomized to the WT-CPT arm will receive 6 weeks of computerized word game training and then 6 weeks of standard Cognitive Processing Therapy for PTSD (total of 12 sessions)
40
Total82

Baseline characteristics

CharacteristicCEFT-CPTWT-CPTTotal
Age, Continuous37.07 Years
STANDARD_DEVIATION 8.14
38.40 Years
STANDARD_DEVIATION 8.31
37.72 Years
STANDARD_DEVIATION 8.2
Education in years14.93 years
STANDARD_DEVIATION 1.83
15.25 years
STANDARD_DEVIATION 2.1
15.09 years
STANDARD_DEVIATION 1.96
Ethnicity (NIH/OMB)
Hispanic or Latino
10 Participants15 Participants25 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
32 Participants24 Participants56 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Region of Enrollment
United States
42 Participants40 Participants82 Participants
Sex: Female, Male
Female
12 Participants11 Participants23 Participants
Sex: Female, Male
Male
30 Participants29 Participants59 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 420 / 40
other
Total, other adverse events
0 / 420 / 40
serious
Total, serious adverse events
0 / 420 / 40

Outcome results

Primary

Behavior Rating Inventory of Executive Function (BRIEF)

Behavior Rating Inventory of Executive Function (BRIEF) is a self-report measure of executive functioning, items are summed to create a total score, range: -32 to 30, higher scores mean a worse outcome

Time frame: change in subjective executive functioning from baseline to completion of computerized cognitive training (6 weeks)

Population: Two participants did not complete this measure prior to being lost to follow-up

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTBehavior Rating Inventory of Executive Function (BRIEF)-6.52 score on a scaleStandard Deviation 12.39
WT-CPTBehavior Rating Inventory of Executive Function (BRIEF)-3.50 score on a scaleStandard Deviation 16.29
Primary

Delis Kaplan Executive Function System (D-KEFS)

Delis Kaplan Executive Function System (D-KEFS) is a neuropsychological measure of executive functioning, will be examined separately as well as in a composite with the other neuropsychological measures of executive functioning, range: -39 to 27, higher scores mean a worse outcome

Time frame: change from baseline to completion of computerized cognitive training (6 weeks)

Population: A participant was not able to complete this measure due to color blindness

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTDelis Kaplan Executive Function System (D-KEFS)-4.90 score on a scaleStandard Deviation 8.83
WT-CPTDelis Kaplan Executive Function System (D-KEFS)-3.81 score on a scaleStandard Deviation 10.05
Primary

Go/No-Go Task Performance

Go/No-Go is a task that tests executive functioning, range: -.04 to .02, higher scores mean a worse outcome

Time frame: change from baseline to completion of computerized cognitive training (6 weeks)

Population: Some participants were unable to complete this measure due to COVID restrictions related to in-person study visits

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTGo/No-Go Task Performance-.01 score on a scaleStandard Deviation 0.01
WT-CPTGo/No-Go Task Performance-.001 score on a scaleStandard Deviation 0.02
Primary

N-Back Task Performance

N-Back is a task that tests executive functioning, range: -.25 to .28, higher scores means a better outcome

Time frame: change from baseline to completion of computerized cognitive training (6 weeks)

Population: Some participants were unable to complete this measure due to COVID restrictions related to in-person study visits

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTN-Back Task Performance.04 score on a scaleStandard Deviation 0.12
WT-CPTN-Back Task Performance-.01 score on a scaleStandard Deviation 0.11
Primary

Paced Auditory Serial Addition Test (PASAT)

Paced Auditory Serial Addition Test (PASAT) is a neuropsychological measure of executive functioning, will be examined separately as well as in a composite with the other neuropsychological measures of executive functioning, range: -22 to 47, higher scores mean a better outcome

Time frame: change from baseline to completion of computerized cognitive training (6 weeks)

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTPaced Auditory Serial Addition Test (PASAT)14.32 score on a scaleStandard Deviation 13.03
WT-CPTPaced Auditory Serial Addition Test (PASAT)10.88 score on a scaleStandard Deviation 14.61
Primary

WAIS-IV Digit Span Sequencing Subtest

Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) Digit Span Sequencing subtest is a neuropsychological measure of executive functioning, will be examined separately as well as in a composite with the other neuropsychological measures of executive functioning, range: -3 to 3, higher scores mean a better outcome

Time frame: change from baseline to completion of computerized cognitive training (6 weeks)

Population: One participant did not complete this measure prior to being lost to follow-up

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTWAIS-IV Digit Span Sequencing Subtest1.03 score on a scaleStandard Deviation 1.63
WT-CPTWAIS-IV Digit Span Sequencing Subtest.31 score on a scaleStandard Deviation 1.57
Primary

Wisconsin Card Sorting Test (WCST)

Wisconsin Card Sorting Test (WCST) is a neuropsychological measure of executive functioning, will be examined separately as well as in a composite with the other neuropsychological measures of executive functioning, range: -22 to 15, higher scores mean a worse outcome

Time frame: change from baseline to completion of computerized cognitive training (6 weeks)

Population: Two participants did not complete this measure prior to being lost to follow-up

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTWisconsin Card Sorting Test (WCST)-2.69 score on a scaleStandard Deviation 4.24
WT-CPTWisconsin Card Sorting Test (WCST)-1.47 score on a scaleStandard Deviation 6.41
Secondary

Clinician-Administered PTSD Scale for DSM 5 (CAPS-5)

Clinician-Administered PTSD Scale for DSM 5 (CAPS-5) is a clinical interview assessing PTSD symptoms that will be administered at 3 time points: baseline, after completion of cognitive training, and after completion of Cognitive Processing Therapy, range: -38 to 18, higher scores mean a worse outcome

Time frame: change in PTSD symptoms from baseline to completion of Cognitive Processing Therapy (12 sessions completed after cognitive training), approximately 12 weeks after baseline assessment

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTClinician-Administered PTSD Scale for DSM 5 (CAPS-5)-8.18 score on a scaleStandard Deviation 13.2
WT-CPTClinician-Administered PTSD Scale for DSM 5 (CAPS-5)-4.96 score on a scaleStandard Deviation 11.67
Secondary

Number of CPT Sessions Completed

Number of CPT sessions completed out of a possible total of 12 sessions

Time frame: CPT sessions completed (out of a possible 12) after completing the cognitive training (across approximately 6 weeks, weeks 7-12 after baseline)

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTNumber of CPT Sessions Completed6.76 number of CPT sessions completedStandard Deviation 5.56
WT-CPTNumber of CPT Sessions Completed7.78 number of CPT sessions completedStandard Deviation 5.31
Secondary

PTSD Checklist for DSM-5 (PCL-5)

PTSD Checklist for DSM-5 (PCL-5) is a self-report questionnaire that will be administered at 15 time points: at baseline, after completion of cognitive training, at each of the 12 therapy sessions, and after completion of Cognitive Processing Therapy, range: -49 to 28, higher scores mean a worse outcome

Time frame: change in PTSD symptoms from baseline to completion of Cognitive Processing Therapy (12 sessions completed after cognitive training), approximately 12 weeks after baseline assessment

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTPTSD Checklist for DSM-5 (PCL-5)-12.64 score on a scaleStandard Deviation 17.85
WT-CPTPTSD Checklist for DSM-5 (PCL-5)-11.70 score on a scaleStandard Deviation 12.32
Secondary

Time (in Minutes) Spent Completing Cognitive Processing Therapy Homework

At each of the CPT sessions, participants will report how much time they spent completing homework since the previous session

Time frame: time (in minutes) spent completing homework from CPT session 1 to CPT session 12 (across approximately 6 weeks, weeks 7-12 after baseline)

Population: Number of participants reflect only those participants who completed at least 2 sessions of CPT (i.e., enough sessions to complete at least one homework assignment)

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTTime (in Minutes) Spent Completing Cognitive Processing Therapy Homework426.68 minutesStandard Deviation 356.59
WT-CPTTime (in Minutes) Spent Completing Cognitive Processing Therapy Homework448.28 minutesStandard Deviation 610.06
Secondary

World Health Organization Quality of Life - BREF

World Health Organization Quality of Life - BREF (WHOQOL-BREF) is a self-report questionnaire assessing quality of life that will be administered at 3 time points: baseline, after completion of cognitive training, and after completion of Cognitive Processing Therapy. Four subscales are computed (range 4-20): physical health, psychological, social relationships, and environment, range: -2.7 to 6.7, higher scores mean a better outcome

Time frame: change in quality of life from baseline to completion of Cognitive Processing Therapy (12 sessions completed after cognitive training), approximately 12 weeks after baseline assessment

ArmMeasureValue (MEAN)Dispersion
CEFT-CPTWorld Health Organization Quality of Life - BREF1.61 score on a scaleStandard Deviation 2.52
WT-CPTWorld Health Organization Quality of Life - BREF1.39 score on a scaleStandard Deviation 2.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026